Director/PDMR Shareholding

Summary by AI BETAClose X

PureTech Health plc announced that several Persons Discharging Managerial Responsibilities (PDMRs), including the Chief Executive Officer and Non-Executive Directors, purchased an aggregate of 147,849 ordinary shares on the London Stock Exchange between July 7th and 8th, 2026, at a price of GBP 1.19 per share. This initial notification details transactions made by Robert Lyne, Sharon Barber-Lui, John LaMattina, and Michele Holcomb, indicating their continued investment in the company.

Disclaimer*

PureTech Health PLC
09 July 2026
 

PDMR DEALING NOTIFICATION

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Robert Lyne

Sharon Barber-Lui

John LaMattina

Michele Holcomb

2

Reason for the notification

a)

Position/status

Robert Lyne - Chief Executive Officer, Executive Director

Sharon Barber-Lui - Interim Board Chair; Non-Executive Director

John LaMattina - Non-Executive Director

Michele Holcomb - Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

PureTech Health plc

b)

LEI

213800LVPDNO2Z9T9I39

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of PureTech Health plc



ISIN GB00BY2Z0H74

b)

Nature of the transaction

Purchase of shares in market

c)

Price(s) and volume(s)

Name

Price(s)

Volume(s)

Robert Lyne

GBP 1.19 per share

36,500

Sharon Barber-Lui

GBP 1.19 per share

29,868

John LaMattina

GBP 1.19 per share

50,000

Michele Holcomb

GBP 1.19 per share

31,481

d)

Aggregated information

-

Aggregated volume

-

Price

 

Price

Aggregate Volume

GBP 1.19 per share

147,849

e)

Date of the transaction

7-8 July 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings